Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia

Cancer Cell

Volumn 22, Issue 4, 2012, Pages 452-465

  Sawai, Catherine M ^a   Freund, Jacquelyn ^a   Oh, Philmo ^a   Ndiaye Lobry, Delphine ^a   Bretz, Jamieson C ^b   Strikoudis, Alexandros ^a   Genesca, Lali ^c   Trimarchi, Thomas ^a   Kelliher, Michelle A ^d   Clark, Marcus ^e   Soulier, Jean ^c   Chen Kiang, Selina ^b   Aifantis, Iannis ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Institut Universitaire d'Hématologie   (France)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ACETYL 8 CYCLOPENTYL 5 METHYL 2 [5 (1 PIPERAZINYL) 2 PYRIDINYLAMINO] 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; ANTINEOPLASTIC AGENT; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PROTEIN P27;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINOBLASTOMA; T CELL LEUKEMIA; THYMOCYTE;

EID: 84867602759     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.09.016     Document Type: Article

References (48)

1. Aifantis I., Raetz E., Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol. 2008, 8:380-390.
2. Baker G.L., Landis M.W., Hinds P.W. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle 2005, 4:330-338.
3. Baughn L.B., Di Liberto M., Wu K., Toogood P.L., Louie T., Gottschalk R., Niesvizky R., Cho H., Ely S., Moore M.A., Chen-Kiang S. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6. Cancer Res. 2006, 66:7661-7667.
4. Bergsagel P.L., Kuehl W.M., Zhan F., Sawyer J., Barlogie B., Shaughnessy J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005, 106:296-303.
5. Carthon B.C., Neumann C.A., Das M., Pawlyk B., Li T., Geng Y., Sicinski P. Genetic replacement of cyclin D1 function in mouse development by cyclin D2. Mol. Cell. Biol. 2005, 25:1081-1088.
6. Chien W.M., Rabin S., Macias E., Miliani de Marval P.L., Garrison K., Orthel J., Rodriguez-Puebla M., Fero M.L. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1. Proc. Natl. Acad. Sci. USA 2006, 103:4122-4127.
7. Ciemerych M.A., Kenney A.M., Sicinska E., Kalaszczynska I., Bronson R.T., Rowitch D.H., Gardner H., Sicinski P. Development of mice expressing a single D-type cyclin. Genes Dev. 2002, 16:3277-3289.
8. Clappier E., Gerby B., Sigaux F., Delord M., Touzri F., Hernandez L., Ballerini P., Baruchel A., Pflumio F., Soulier J. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J. Exp. Med. 2011, 208:653-661.
9. Cooper A.B., Sawai C.M., Sicinska E., Powers S.E., Sicinski P., Clark M.R., Aifantis I. A unique function for cyclin D3 in early B cell development. Nat. Immunol. 2006, 7:489-497.
10. Coustan-Smith E., Mullighan C.G., Onciu M., Behm F.G., Raimondi S.C., Pei D., Cheng C., Su X., Rubnitz J.E., Basso G., et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009, 10:147-156.
11. Dean J.L., Thangavel C., McClendon A.K., Reed C.A., Knudsen E.S. Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene 2010, 29:4018-4032.
12. Espinosa L., Cathelin S., D'Altri T., Trimarchi T., Statnikov A., Guiu J., Rodilla V., Inglés-Esteve J., Nomdedeu J., Bellosillo B., et al. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Cancer Cell 2010, 18:268-281.
13. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996, 85:733-744.
14. Fry D.W., Harvey P.J., Keller P.R., Elliott W.L., Meade M., Trachet E., Albassam M., Zheng X., Leopold W.R., Pryer N.K., Toogood P.L. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol. Cancer Ther. 2004, 3:1427-1438.
15. Geng Y., Whoriskey W., Park M.Y., Bronson R.T., Medema R.H., Li T., Weinberg R.A., Sicinski P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 1999, 97:767-777.
16. Geng Y., Yu Q., Sicinska E., Das M., Bronson R.T., Sicinski P. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc. Natl. Acad. Sci. USA 2001, 98:194-199.
17. Hunter T., Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582.
18. Joshi I., Minter L.M., Telfer J., Demarest R.M., Capobianco A.J., Aster J.C., Sicinski P., Fauq A., Golde T.E., Osborne B.A. Notch signaling mediates G1/S cell cycle progression in T cells via cyclin D3 and its dependent kinases. Blood 2009, 113:1689-1698.
19. Kozar K., Ciemerych M.A., Rebel V.I., Shigematsu H., Zagozdzon A., Sicinska E., Geng Y., Yu Q., Bhattacharya S., Bronson R.T., et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004, 118:477-491.
20. Li X., Gounari F., Protopopov A., Khazaie K., von Boehmer H. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J. Exp. Med. 2008, 205:2851-2861.
21. Malumbres M., Sotillo R., Santamaría D., Galán J., Cerezo A., Ortega S., Dubus P., Barbacid M. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 2004, 118:493-504.
22. Marzec M., Kasprzycka M., Lai R., Gladden A.B., Wlodarski P., Tomczak E., Nowell P., Deprimo S.E., Sadis S., Eck S., et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 2006, 108:1744-1750.
23. Menu E., Garcia J., Huang X., Di Liberto M., Toogood P.L., Chen I., Vanderkerken K., Chen-Kiang S. A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma model. Cancer Res. 2008, 68:5519-5523.
24. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
25. Motokura T., Arnold A. Cyclin D and oncogenesis. Curr. Opin. Genet. Dev. 1993, 3:5-10.
26. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y., Nakayama K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720.
27. O'Neil J., Calvo J., McKenna K., Krishnamoorthy V., Aster J.C., Bassing C.H., Alt F.W., Kelliher M., Look A.T. Activating Notch1 mutations in mouse models of T-ALL. Blood 2006, 107:781-785.
28. Palomero T., Sulis M.L., Cortina M., Real P.J., Barnes K., Ciofani M., Caparros E., Buteau J., Brown K., Perkins S.L., et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat. Med. 2007, 13:1203-1210.
29. Peled J.U., Yu J.J., Venkatesh J., Bi E., Ding B.B., Krupski-Downs M., Shaknovich R., Sicinski P., Diamond B., Scharff M.D., Ye B.H. Requirement for cyclin D3 in germinal center formation and function. Cell Res. 2010, 20:631-646.
30. Rane S.G., Dubus P., Mettus R.V., Galbreath E.J., Boden G., Reddy E.P., Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 1999, 22:44-52.
31. Real P.J., Tosello V., Palomero T., Castillo M., Hernando E., de Stanchina E., Sulis M.L., Barnes K., Sawai C., Homminga I., et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat. Med. 2009, 15:50-58.
32. Sarcevic B., Lilischkis R., Sutherland R.L. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes. J. Biol. Chem. 1997, 272:33327-33337.
33. Schwartz G.K., LoRusso P.M., Dickson M.A., Randolph S.S., Shaik M.N., Wilner K.D., Courtney R., O'Dwyer P.J. Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1). Br. J. Cancer 2011, 104:1862-1868.
34. Sherr C.J. D-type cyclins. Trends Biochem. Sci. 1995, 20:187-190.
35. Sherr C.J., Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004, 18:2699-2711.
36. Sicinska E., Aifantis I., Le Cam L., Swat W., Borowski C., Yu Q., Ferrando A.A., Levin S.D., Geng Y., von Boehmer H., Sicinski P. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003, 4:451-461.
37. Sicinska E., Lee Y.M., Gits J., Shigematsu H., Yu Q., Rebel V.I., Geng Y., Marshall C.J., Akashi K., Dorfman D.M., et al. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes. Mol. Cell. Biol. 2006, 26:8052-8060.
38. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995, 82:621-630.
39. Sicinski P., Donaher J.L., Geng Y., Parker S.B., Gardner H., Park M.Y., Robker R.L., Richards J.S., McGinnis L.K., Biggers J.D., et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996, 384:470-474.
40. Solvason N., Wu W.W., Parry D., Mahony D., Lam E.W., Glassford J., Klaus G.G., Sicinski P., Weinberg R., Liu Y.J., et al. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int. Immunol. 2000, 12:631-638.
41. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
42. Tamamori-Adachi M., Goto I., Yamada K., Kitajima S. Differential regulation of cyclin D1 and D2 in protecting against cardiomyocyte proliferation. Cell Cycle 2008, 7:3768-3774.
43. Tsutsui T., Hesabi B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol. Cell. Biol. 1999, 19:7011-7019.
44. Vilimas T., Mascarenhas J., Palomero T., Mandal M., Buonamici S., Meng F., Thompson B., Spaulding C., Macaroun S., Alegre M.L., et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat. Med. 2007, 13:70-77.
45. Walkley C.R., Fero M.L., Chien W.M., Purton L.E., McArthur G.A. Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 2005, 7:172-178.
46. Walkley C.R., Shea J.M., Sims N.A., Purton L.E., Orkin S.H. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007, 129:1081-1095.
47. Weng A.P., Ferrando A.A., Lee W., Morris J.P., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269-271.
48. Zou P., Yoshihara H., Hosokawa K., Tai I., Shinmyozu K., Tsukahara F., Maru Y., Nakayama K., Nakayama K.I., Suda T. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 2011, 9:247-261.